Emergent and J&J settle dispute over COVID vaccine supplies
Emergent BioSolutions said Monday that Johnson & Johnson has agreed to pay $50 million to settle claims related to a terminated COVID-19 vaccine deal. The company’s shares rose about 2 per cent in extended trading.
POPULAR POSTS
IEA warns ‘electricity era’ will come after fossil fuels peak
October 17, 2024
Easter Island fights global plastic waste vortex
October 17, 2024
Egypt opens more galleries at its antiquities museum
October 17, 2024
LIVE STREAM